Raptor Pharmaceuticals joins the Intercept rally

|About: Raptor Pharmaceutical Corp. (RPTP)|By:, SA News Editor

Add Raptor Pharmaceuticals (RPTP) to the list of stocks benefiting from the rally in liver disease plays sparked Thursday by ICPT.

The company — which is developing RP103 for NAFLD — saw its shares rise 6% yesterday, and early trading suggests today will be another positive session.

RPTP +7.5% premarket

See also: GALT, CNAT piggyback on ICPT NASH results